Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2758
Title: THE HEART INSTITUTE LUNG TRANSPLANT REGISTRY: REPORT OF RESULTS FROM 2003 TO 2012
Authors: CARAMORI, M. L.FERNANDES, L. M.AFONSO JUNIOR, J. E.TEIXEIRA, R. O. B.CAMPOS, S. V.CARRARO, R. M.SAMANO, M. N.PEGO-FERNANDES, P. M.JATENE, F. B.
Citation: PEDIATRIC TRANSPLANTATION, v.17, n.2, p.193-193, 2013
Abstract: OBJECTIVE: The aim of this study was to analyze the outcome of patients who underwent lung transplantation at a single center over a 9 yr period. INTRODUCTION: Lung diseases comprise a heterogeneous group of patients which may lead to end stage lung disease and referral for lung transplantation. This procedure has become a therapeutic option for patients with advanced pulmonary diseases due to improvements in organ conservation, surgical technique, immunosuppressive therapy and treatment of post-operative infections.METHODS: A retrospective study using chart review collected data was performed on all patients transplanted between August, 2003 and August, 2012 at The Heart Institute, São Paulo, Brazil. Multiple pre-transplant characteristics and post-transplant survival were analyzed. RESULTS:During 9 yrs we performed 157 lung transplants; 118 (75%) patients underwent bilateral and 39 (25%) single lung transplant. The most common indication was COPD (24.2%), followed by Cystic Fibrosis (23.5%), Pulmonary Fibrosis (18.4%), Bronchiectasis (19%), Lymphangioleiomyomatosis (4.4%) and others diseases (10%). A total of 146 lung transplants were performed on patients over the age of 18 yrs. Two patients were less than 12 yrs of age and nine were between 12 to 18 yrs old. The overall 1, 3, 5- and 7-yr survivals were 71.3%, 65%, 63% and 58%, respectively. Among the pediatric and adolescent group the most frequent cause for lung transplantation was cystic fibrosis. There was only one death in this young group of patients. CONCLUSION: These findings confirm the consolidated status of lung transplant in our institution as a therapeutic option for advanced chronic respiratory disease, both in young group as well in adults.
Appears in Collections:

Comunicações em Eventos - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Comunicações em Eventos - HC/InCor
Instituto do Coração - HC/InCor

Comunicações em Eventos - LIM/11
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação

Comunicações em Eventos - LIM/61
LIM/61 - Laboratório de Pesquisa em Cirurgia Torácica


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.